Physician profile
Nana Hawa Yayah Jones
NPI 1154596518
$91,857.14
in general payments reported to CMS, 2019-2025
16 companies · $4,598 in 2025
The $4,598 reported for 2025 was more than what 83% of Pediatric Endocrinology providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,327 · 2020: $3,072 · 2021: $34K · 2022: $29K · 2023: $15K · 2024: $4,257 · 2025: $4,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $4,420 · Food and Beverage: $3,747 · Consulting Fee: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,524.00 |
| Travel and Lodging | $4,420.31 |
| Food and Beverage | $3,746.59 |
| Consulting Fee | $310.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $79,843.78 | 2021-2025 | Inpen Smart Insulin Delivery System, Minimed 780g, Minimed 770g |
| Companion Medical, INC. | $3,000.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $2,835.25 | 2023-2025 | |
| Ibsa Institut Biochimique Sa | $2,376.83 | 2023 | Tirosint |
| Tandem Diabetes Care, INC. | $863.18 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $654.74 | 2022-2024 | |
| Dexcom, INC. | $519.10 | 2019-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Novo Nordisk INC | $486.96 | 2019-2024 | |
| Insulet Corporation | $441.22 | 2019-2024 | Omnipod |
| Beta Bionics, INC. | $148.50 | 2024 | Ilet Bionic Pancreas |
| Endo USA, INC. | $139.30 | 2024 | Supprelin |
| Eton Pharmaceuticals, INC. | $125.53 | 2025 | Alkindi, Increlex, Khindivi |
| Gynesonics, INC. | $123.97 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mannkind Corporation | $117.72 | 2025 | |
| Sequel Med Tech, LLC | $111.97 | 2025 | Twiist |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $69.09 | 2023 | Voxzogo 1.2mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nana Hawa Yayah Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.